Cognitive Function and Statin Administration During Doxorubicin-Based Cancer Treatment

1. Statin use in cancer patients was reevaluated. 2. Analysis covered 238 patients with lymphoma or breast cancer. 3. Atorvastatin did not show cognitive decline effects. 4. Cognitive functions improved in statin group for some tests. 5. The study challenges prior beliefs about statins and cognition. 6. Future research is needed for broader implications. 7. Funded by NCORP and related organizations.